Allergic Rhinitis and Asthma Management
Diagnosis and Symptoms
- Patients with allergic rhinitis may exhibit physical examination findings such as clear rhinorrhea, nasal congestion, pale discoloration of nasal mucosa, red and watery eyes, and wheezing on auscultation, according to the American Academy of Otolaryngology-Head and Neck Surgery 1
Treatment Options
- The American Academy of Otolaryngology-Head and Neck Surgery recommends intranasal corticosteroids as first-line treatment for patients whose symptoms affect quality of life 1
- For sneezing and itching, second-generation/less sedating oral antihistamines are recommended, according to the American Academy of Otolaryngology-Head and Neck Surgery 1
- Intranasal antihistamines are considered an alternative for seasonal, perennial, or episodic allergic rhinitis, as suggested by the American Academy of Otolaryngology-Head and Neck Surgery 1
- Oral leukotriene receptor antagonists are not recommended as primary therapy, according to the American Academy of Otolaryngology-Head and Neck Surgery 1
- For inadequate response, combination therapy should be considered, as recommended by the American Academy of Otolaryngology-Head and Neck Surgery 1
- For persistent symptoms despite pharmacotherapy, immunotherapy (sublingual or subcutaneous) may be considered, according to the American Academy of Otolaryngology-Head and Neck Surgery 1
- For severe eosinophilic asthma, anti-IL5 therapies (mepolizumab, benralizumab) may be considered, as suggested by Rhinology guidelines 2
- For type 2 asthma, dupilumab may be considered, according to Rhinology guidelines 2
- The American Academy of Allergy and Clinical Immunology recommends short-acting beta agonists (SABAs) as needed for immediate symptom relief, with potential side effects including tachycardia, tremor, and mild decreases in serum potassium 3
- Low-dose inhaled corticosteroids (ICS) are the preferred controller medication, with examples including fluticasone, budesonide, and beclomethasone, and are the most effective long-term control medication across all age groups 4, 5, 6, 7
Asthma Management
- When symptoms remain uncontrolled on low-dose ICS, the preferred approach is to add a long-acting beta agonist (LABA) to low-dose ICS, which is more effective than increasing the ICS dose alone 6, 5, 7
- Alternative approaches include increasing to medium-dose ICS, adding a leukotriene receptor antagonist to low-dose ICS, or adding theophylline to low-dose ICS 6, 5, 7
- For very severe cases, consider adding oral corticosteroids or omalizumab for allergic phenotypes 6
- For intermittent asthma symptoms, use short-acting beta agonists (SABA) as needed, and for persistent symptoms, add low-dose inhaled corticosteroid, with fluticasone propionate (Flovent) being a first-line option due to potency and efficacy 6, 7
Associated Conditions and Treatment Goals
- Assess and treat associated conditions, such as allergic rhinitis, which may improve overall respiratory control, as recommended by the American Academy of Otolaryngology-Head and Neck Surgery and the Journal of Allergy and Clinical Immunology 1, 8
- Treating allergic rhinitis may improve asthma control in patients with both conditions 8
- The goal of treatment is to achieve and maintain control of symptoms while minimizing the risk of future exacerbations and medication side effects, with regular assessment of symptom control, lung function, medication adherence and technique, and side effects 4, 5, 6, 7, 9
- The treatment goals can be summarized in the following table:
| Goal | Description |
|---|---|
| Minimal symptoms | No or minimal chronic symptoms |
| Minimal rescue medication | Infrequent need for rescue medication |
| No activity limitation | No limitation of activities due to asthma |
| Optimal pulmonary function | Maintenance of optimal pulmonary function |
| Minimal side effects | Minimal medication side effects [9] |
Patient Education and Adherence
- Patients should understand the difference between controller and rescue medications, and self-monitoring of symptoms and peak flow measurements is recommended when appropriate, as suggested by the Mayo Clinic 9
- Poor adherence is a common cause of treatment failure, and addressing adherence is crucial for effective asthma management, as noted by the American Academy of Family Physicians 6
- Proper inhaler technique is essential for effective medication delivery, as emphasized by the American Thoracic Society, and growth monitoring is important in children on inhaled corticosteroid therapy, as recommended by the American Academy of Pediatrics and the American Academy of Family Physicians 5, 7, 10, 6